0001225208-13-013426.txt : 20130529 0001225208-13-013426.hdr.sgml : 20130529 20130529153448 ACCESSION NUMBER: 0001225208-13-013426 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130523 FILED AS OF DATE: 20130529 DATE AS OF CHANGE: 20130529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOREL DONALD E JR CENTRAL INDEX KEY: 0001213306 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 13878241 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 GORDON DR STREET 2: P O BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE STREET 2: PO BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 4 1 doc4.xml X0306 4 2013-05-23 0000105770 WEST PHARMACEUTICAL SERVICES INC WST 0001213306 MOREL DONALD E JR 530 HERMAN O. WEST DRIVE EXTON PA 19341 1 Chair of the Board & CEO Common Stock 2013-05-23 4 M 0 100825.0000 41.7000 A 603993.4076 D Common Stock 2013-05-23 4 M 0 96576.0000 44.9700 A 700569.4076 D Common Stock 2013-05-23 4 F 0 79142.0000 67.6100 D 621427.4076 D Common Stock 2013-05-23 4 F 0 79995.0000 67.6100 D 541432.4076 D Common Stock 2013-05-28 4 S 0 5000.0000 68.0390 D 536432.4076 D Common Stock 2013-05-28 4 S 0 5000.0000 67.7030 D 531432.4076 D Common Stock 2013-05-24 4 A 0 18.8400 67.3800 A 20527.2048 I Non-Qualified Deferred Compensation Plan Common Stock 1335.6398 I By Savings Plan Stock Option (Right to Buy) 41.7000 2013-05-23 4 M 0 100825.0000 41.7000 D 2009-02-26 2018-02-26 Common Stock 100825.0000 0.0000 D Stock Option (Right to Buy) 44.9700 2013-05-23 4 M 0 96576.0000 44.9700 D 2008-02-27 2018-02-27 Common Stock 96576.0000 0.0000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.48 to $68.30, inclusive. The reporting person undertakes to provide to any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in foonotes (1) and (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.45 to $67.98, inclusive. Joanne K. Boyle as Agent for Donald E. Morel, Jr. 2013-05-29